Pure Health Holding PJSC

Ticker/ISIN
PUREHEALTH
AEE01362P238
Market/Country
Abu Dhabi Stock Exchange
United Arab Emirates
Latest Stock Price
4.45 AED
2024-02-21

Year to date

-0.22 %

3 months

0.00 %

6 months

0.00 %

1 year

0.00 %

3 years

0.00 %

5 years

0.00 %

Latest Pressrelease Summaries

Pure Health Holding PJSC
**Summary:** PureHealth, the largest healthcare platform in the Middle East, has contributed AED 1 billion to local procurement since Q1 2023 to support the UAE's National In-Country Value (ICV) Programme. This initiative is part of the UAE's industrial strategy, aiming to boost the industrial sector's GDP contribution to AED 300 billion by 2031. During the Make it in the Emirates Forum, PureHealth confirmed its progress towards a target of AED 13 billion in local procurement by 2032. The company has also implemented ICV strategies across its operations, including subsidiaries like SEHA and Daman, achieving high ICV scores. These efforts underscore PureHealth's role in driving economic diversity, creating local jobs, and enhancing healthcare services in the UAE.
Pure Health Holding PJSC
In Q1 2024, PureHealth reported a net profit of AED 491 million, a 124% increase from Q1 2023. The company's EBITDA also rose to AED 1.1 billion, a 2.3x increase from the previous year. This reflects improved operational efficiencies across all key segments. PureHealth's consolidated revenue increased by 52% to AED 6.1 billion, led by the Hospital and Other Related Services segment. The company completed the acquisition of Circle Health Group and Sheikh Shakhbout Medical City, significantly expanding its global presence. The firm's total assets increased to AED 47.3 billion, with a total cash balance of AED 8.0 billion. PureHealth's balance sheet reported a net cash balance of AED 4.4 billion as of 31 March 2024.
Pure Health Holding PJSC
The text refers to the interim condensed consolidated financial statements of Pure Health Holding PJSC for the period ending on 31 March 2024. It is likely to contain financial information and performance indicators relevant to investors and those interested in the company's financial health.
Pure Health Holding PJSC
The text appears to be an interim condensed consolidated financial statement from Pure Health Holding PJSC, for the period ending on 31 March 2024. These types of documents typically contain a summary of a company's financial performance over a specific period, including revenues, expenses, and net income.
Pure Health Holding PJSC
Resolution No. 283 of 2024 temporarily suspends trading of Pure Health Holding PJSC shares on the ADX. This is due to a Board of Directors meeting scheduled for 13:00 on 12th February 2024, which coincides with the ADX trading session. Trading will be suspended from 09:00 on the same day until the ADX receives the meeting results. All department heads in ADX are instructed to execute this resolution in their respective fields. The resolution will be circulated to SCA, the concerned company, all departments at ADX, and all brokers accredited by ADX. The resolution was approved by the authorized person and issued on 08/02/2024.

Threads

Page 1
Abu Dhabi Stock Exchange News

Abu Dhabi Stock Exchange News

News Update From Pure Health Holding PJSC

Disclosures: Pure Health Holding PJSC_Disclosure of Material Information_Sale of Abu Dhabi Stem Cells Center and Yas Clinic

1. Attached Document

Abu Dhabi Stock Exchange News

Abu Dhabi Stock Exchange News

News Update From Pure Health Holding PJSC

Disclosures: Pure Health Holding PJSC Board Meeting Results held on 27/06/2024 at 15:30

1. Attached Document

Abu Dhabi Stock Exchange News

Abu Dhabi Stock Exchange News

News Update From Pure Health Holding PJSC

Disclosures: Pure Health Holding PJSC Announcement of Board Meeting to be held on 27/06/2024 at 15:30

1. Attached Document

Abu Dhabi Stock Exchange News

Abu Dhabi Stock Exchange News

News Update From Pure Health Holding PJSC

Disclosures: Pure Health Holding PJSC General Press Release_National ICV programme Support

**Summary:** PureHealth, the largest healthcare platform in the Middle East, has contributed AED 1 billion to local procurement since Q1 2023 to support the UAE's National In-Country Value (ICV) Programme. This initiative is part of the UAE's industrial strategy, aiming to boost the industrial sector's GDP contribution to AED 300 billion by 2031. During the Make it in the Emirates Forum, PureHealth confirmed its progress towards a target of AED 13 billion in local procurement by 2032. The company has also implemented ICV strategies across its operations, including subsidiaries like SEHA and Daman, achieving high ICV scores. These efforts underscore PureHealth's role in driving economic diversity, creating local jobs, and enhancing healthcare services in the UAE.

1. Attached Document

Abu Dhabi Stock Exchange News

Abu Dhabi Stock Exchange News

News Update From Pure Health Holding PJSC

Disclosures: Pure Health Holding PJSC Management Discussion and Analysis Report for the Period Ended March 31,2024

In Q1 2024, PureHealth reported a net profit of AED 491 million, a 124% increase from Q1 2023. The company's EBITDA also rose to AED 1.1 billion, a 2.3x increase from the previous year. This reflects improved operational efficiencies across all key segments. PureHealth's consolidated revenue increased by 52% to AED 6.1 billion, led by the Hospital and Other Related Services segment. The company completed the acquisition of Circle Health Group and Sheikh Shakhbout Medical City, significantly expanding its global presence. The firm's total assets increased to AED 47.3 billion, with a total cash balance of AED 8.0 billion. PureHealth's balance sheet reported a net cash balance of AED 4.4 billion as of 31 March 2024.

1. Attached Document

Abu Dhabi Stock Exchange News

Abu Dhabi Stock Exchange News

News Update From Pure Health Holding PJSC

Disclosures: Pure Health Holding PJSC Financial Results for the Period Ended March 31,2024

The text refers to the interim condensed consolidated financial statements of Pure Health Holding PJSC for the period ending on 31 March 2024. It is likely to contain financial information and performance indicators relevant to investors and those interested in the company's financial health.

1. Attached Document

Abu Dhabi Stock Exchange News

Abu Dhabi Stock Exchange News

News Update From Pure Health Holding PJSC

Disclosures: Pure Health Holding PJSC_Appointment of new Board of Directors member

1. Attached Document

Abu Dhabi Stock Exchange News

Abu Dhabi Stock Exchange News

News Update From Pure Health Holding PJSC

Disclosures: Pure Health Holding PJSC Financial Results for the Period Ended March 31,2024

The text appears to be an interim condensed consolidated financial statement from Pure Health Holding PJSC, for the period ending on 31 March 2024. These types of documents typically contain a summary of a company's financial performance over a specific period, including revenues, expenses, and net income.

1. Attached Document

Abu Dhabi Stock Exchange News

Abu Dhabi Stock Exchange News

News Update From Pure Health Holding PJSC

Disclosures: Pure Health Holding PJSC Board Meeting Results held on 01/05/2024 at 15:00

1. Attached Document

Abu Dhabi Stock Exchange News

Abu Dhabi Stock Exchange News

News Update From Pure Health Holding PJSC

Disclosures: Pure Health Holding PJSC Announcement of Board Meeting to be held on 01/05/2024 at 15:00

1. Attached Document

Page 1